| Not Yet Recruiting | Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC) NCT07226037 | Boston Medical Center | N/A |
| Not Yet Recruiting | Navigation Intervention for Adolescent and Young Adult Cancer Survivors NCT07406087 | Kaiser Permanente | N/A |
| Not Yet Recruiting | Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer NCT05521997 | Washington University School of Medicine | Phase 2 |
| Not Yet Recruiting | My Self-Sampling for HPV Awareness, Results, and Empowerment NCT07296159 | Daisy Le | N/A |
| Not Yet Recruiting | Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Im NCT06850402 | M.D. Anderson Cancer Center | N/A |
| Not Yet Recruiting | Adaptive Radiotherapy for Safe Hypofractionation NCT07516210 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 |
| Not Yet Recruiting | Effect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in Women NCT07521163 | Muhammet Faruk Yigit | N/A |
| Not Yet Recruiting | Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors NCT07524322 | Regor Pharmaceuticals Inc. | Phase 1 |
| Not Yet Recruiting | JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer NCT07497074 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Phase 2 |
| Not Yet Recruiting | Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies NCT07447895 | University of Cincinnati | N/A |
| Not Yet Recruiting | A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy NCT07466901 | Jin LI | N/A |
| Not Yet Recruiting | C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the Unite NCT07520188 | UNC Lineberger Comprehensive Cancer Center | — |
| Not Yet Recruiting | Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening NCT07453459 | Washington University School of Medicine | N/A |
| Recruiting | Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda NCT07276360 | Uganda Cancer Institute | Phase 2 |
| Not Yet Recruiting | Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer NCT07412873 | Fundacion Clinic per a la Recerca Biomédica | Phase 4 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 NCT05570422 | Kortuc, Inc. | Phase 1 |
| Not Yet Recruiting | GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries NCT07415681 | University of Maryland, Baltimore | Phase 2 |
| Withdrawn | Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Pop NCT07211204 | Timser SAPI de CV | N/A |
| Recruiting | 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors NCT07189871 | Radiopharm Theranostics, Ltd | Phase 1 / Phase 2 |
| Recruiting | Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) NCT07225530 | Columbia University | N/A |
| Not Yet Recruiting | Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometria NCT07382505 | Asan Medical Center | — |
| Recruiting | Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial NCT07227077 | Medical College of Wisconsin | N/A |
| Not Yet Recruiting | A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Lo NCT07348861 | Zheng Min | Phase 2 |
| Not Yet Recruiting | A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer NCT07363330 | Zhongnan Hospital | Phase 2 |
| Recruiting | Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917 | University of California, Irvine | N/A |
| Recruiting | SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer NCT07256236 | Fujian Cancer Hospital | Phase 2 |
| Recruiting | Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening NCT06527456 | Centre Hospitalier Intercommunal Creteil | N/A |
| Not Yet Recruiting | The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients NCT07385976 | Far Eastern Memorial Hospital | — |
| Recruiting | A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-lin NCT07216703 | Merck Sharp & Dohme LLC | Phase 3 |
| Not Yet Recruiting | Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy NCT07318701 | Obstetrics & Gynecology Hospital of Fudan University | N/A |
| Not Yet Recruiting | Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receivi NCT07362147 | Taipei Veterans General Hospital, Taiwan | N/A |
| Recruiting | Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Foll NCT07214584 | University of Florida | — |
| Recruiting | Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Ca NCT07439497 | Samsung Medical Center | Phase 2 |
| Recruiting | Serplulimab for Locally Advanced Cervical Cancer NCT07340489 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya NCT07050745 | Kenyatta National Hospital | N/A |
| Not Yet Recruiting | A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combi NCT06760676 | Anhui Provincial Hospital | Phase 1 |
| Not Yet Recruiting | SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer NCT07230626 | CSPC Megalith Biopharmaceutical Co.,Ltd. | Phase 3 |
| Enrolling By Invitation | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid T NCT07218003 | Rondo Therapeutics | Phase 1 |
| Recruiting | Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors NCT07081984 | Therorna | Phase 1 |
| Recruiting | A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer NCT07227168 | Sutro Biopharma, Inc. | Phase 1 |
| Recruiting | Patient Preference for Subcutaneous vs. Intravenous Immune Therapy NCT07223424 | Diwakar Davar | Phase 2 |
| Recruiting | Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Prog NCT05286034 | International Agency for Research on Cancer | N/A |
| Recruiting | A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors NCT07182149 | Normunity AccelCo, Inc. | Phase 1 |
| Recruiting | PopSci CHW4CervixHealth NCT07336134 | Thomas Jefferson University | N/A |
| Not Yet Recruiting | Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV NCT07090174 | Weill Medical College of Cornell University | Phase 2 |
| Not Yet Recruiting | Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV NCT06182241 | Boston University Charles River Campus | N/A |
| Recruiting | The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Map NCT07380698 | Cukurova University | — |
| Not Yet Recruiting | Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical NCT07177716 | L & L Bio Co., Ltd., Ningbo, China | Phase 2 / Phase 3 |
| Not Yet Recruiting | QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therap NCT07141186 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | Extended-field Proton Therapy for Cervical Cancer NCT07298642 | National Taiwan University Hospital | Phase 2 / Phase 3 |
| Recruiting | A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations NCT07109726 | Terremoto Biosciences Inc. | Phase 1 / Phase 2 |
| Recruiting | Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer NCT07080216 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Phase 1 / Phase 2 |
| Recruiting | A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients NCT06315257 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Recruiting | Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retro NCT07120529 | Medical University of Silesia | — |
| Recruiting | CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors NCT07181720 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496 | University of Arizona | Phase 1 / Phase 2 |
| Recruiting | A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizu NCT06232083 | Anhui Provincial Hospital | Phase 1 |
| Not Yet Recruiting | Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines NCT07077980 | Anhui Provincial Hospital | — |
| Not Yet Recruiting | EQUITA - A Feasibility Trial of a Faith-placed Intervention to Increase Screening Uptake in Black Adults NCT06981182 | University of Sunderland | N/A |
| Recruiting | Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology) NCT07120945 | Medtronic - MITG | N/A |
| Recruiting | A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and NCT07054567 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972 | Christian Hinrichs | Phase 1 / Phase 2 |
| Recruiting | Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy NCT07121543 | University of California, San Diego | — |
| Recruiting | A Study of YL202 in Patients With Advanced Solid Tumors NCT07202364 | MediLink Therapeutics (Suzhou) Co., Ltd. | Phase 2 |
| Recruiting | HPV Self-sampling in the General Population NCT06749847 | International Agency for Research on Cancer | N/A |
| Not Yet Recruiting | Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer NCT06977594 | Seoul National University Hospital | N/A |
| Completed | Effect of Prehabilitation on Recovery Outcomes in Post-Surgical Cervical Cancer Women NCT07398313 | Saveetha University | N/A |
| Completed | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors NCT06973161 | AstraZeneca | — |
| Recruiting | A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas NCT06999187 | Dren Bio | Phase 1 |
| Withdrawn | Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer NCT05850663 | University of Oklahoma | N/A |
| Not Yet Recruiting | Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical C NCT06986057 | Shandong Tumor Hospital | Phase 2 |
| Withdrawn | A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Vari NCT04889495 | Pfizer | — |
| Recruiting | Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer NCT06952660 | Pfizer | Phase 4 |
| Recruiting | Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies NCT07064018 | University of California, Irvine | Phase 1 / Phase 2 |
| Enrolling By Invitation | Diagnostic Evaluation of Viral Persistence in Cervical Cancer NCT07325682 | Oncology Center,Ministry Of Heath,Uzbekistan | N/A |
| Recruiting | A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521 | Tanabe Pharma America, Inc. | Phase 1 / Phase 2 |
| Recruiting | Concomitant Curcumin Palliative Radiotherapy in Advanced Cervical Cancer Trial NCT05947513 | Addis Ababa University | N/A |
| Recruiting | A Study of Ivonescimab in People With Endometrial and Cervical Cancers NCT06925724 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine NCT07275333 | Karolinska Institutet | N/A |
| Terminated | Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate NCT05458960 | Washington University School of Medicine | N/A |
| Recruiting | PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cerv NCT06157151 | Precigen, Inc | Phase 2 |
| Not Yet Recruiting | DNA Methylation and the Increased Risk of Cervical Cancer Development NCT06859151 | Zhujiang Hospital | — |
| Not Yet Recruiting | Study on Novel Strategies for Cervical Cancer Screening Using Photoelectric Detection and Epigenetic Procotol NCT06866392 | Peking Union Medical College Hospital | — |
| Recruiting | Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial NCT07167160 | Women's Hospital School Of Medicine Zhejiang University | Phase 2 |
| Not Yet Recruiting | Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma NCT06870565 | Women's Hospital School Of Medicine Zhejiang University | Phase 3 |
| Not Yet Recruiting | Hospital-based Validation of the New ELEVATE Screening Tool NCT06304610 | University Hospital, Ghent | N/A |
| Recruiting | Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Ce NCT06942416 | Shandong Cancer Hospital and Institute | Phase 2 |
| Recruiting | Intra-lesional Tumor Boost for Bulky Cervical Cancer NCT07435376 | Seoul National University Bundang Hospital | Phase 2 |
| Recruiting | A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advan NCT06769152 | Shanghai Henlius Biotech | Phase 2 |
| Not Yet Recruiting | Detection of Peritoneal Metastases by Diagnostic LAparoscopy in Patients With Locally Advanced Cervical Carcin NCT06832397 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL NCT06630611 | Vall d'Hebron Institute of Oncology | Phase 2 |
| Unknown | A Multimodal Intervention Program to Improve Sexual Health and Self-perceived Quality of Life in Patients Trea NCT06031493 | Hospital Clinic of Barcelona | Phase 4 |
| Not Yet Recruiting | Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer NCT06745219 | Peking University Cancer Hospital & Institute | Phase 2 |
| Recruiting | Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663 | RenJi Hospital | Phase 2 / Phase 3 |
| Not Yet Recruiting | Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions NCT06649838 | Peking Union Medical College Hospital | — |
| Recruiting | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin NCT06677190 | Dana-Farber Cancer Institute | Phase 2 |
| Recruiting | Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer i NCT06771193 | MSD Italia S.r.l. | — |
| Not Yet Recruiting | Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer NCT06737640 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Not Yet Recruiting | Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure NCT06681636 | National Institute of Hygiene and Epidemiology, Vietnam | Phase 2 |
| Completed | The Femscope Calm Collect Device NCT06861504 | University of Michigan | N/A |
| Recruiting | Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology NCT06392997 | ZIWIG | — |
| Recruiting | Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HI NCT06751030 | Emory University | — |
| Recruiting | Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy f NCT07092696 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Not Yet Recruiting | Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix. NCT06705322 | Fudan University | Phase 2 |
| Recruiting | Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer NCT06459687 | Lee's Pharmaceutical Limited | Phase 3 |
| Recruiting | Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer NCT06641635 | Peking Union Medical College Hospital | Phase 3 |
| Recruiting | Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor NCT07433283 | Sichuan Enray Pharmaceutical Sciences Company | Phase 1 / Phase 2 |
| Not Yet Recruiting | Correlation Between Selenium Levels in Human Tissues and HPV-related Cervical Lesions and Outcomes NCT06665841 | Second Affiliated Hospital of Wenzhou Medical University | — |
| Recruiting | Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproduc NCT06967740 | Nikola Janovska | — |
| Recruiting | Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer NCT06416748 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Recruiting | Spatially Fractionated Radiation Treatment for Gynaecological Cancers NCT06644846 | Tata Memorial Hospital | N/A |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | HPV Infection and Vaginal Microecology in Immunosuppressed Women NCT06619743 | Lan Zhu | — |
| Enrolling By Invitation | A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Re NCT06755515 | Shandong New Time Pharmaceutical Co., LTD | Phase 2 / Phase 3 |
| Recruiting | Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicen NCT06619002 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | A Study of VET3-TGI in Patients With Solid Tumors NCT06444815 | KaliVir Immunotherapeutics | Phase 1 |
| Not Yet Recruiting | Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer NCT06591078 | Ying Zhang | N/A |
| Recruiting | Neoadjuvant Immunochemotherapy in PD-L1-negative LACC NCT06288360 | Tongji Hospital | Phase 2 |
| Recruiting | A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic C NCT06692166 | Mabwell (Shanghai) Bioscience Co., Ltd. | Phase 3 |
| Recruiting | Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Can NCT06140589 | Fujian Cancer Hospital | — |
| Recruiting | Online Adaptive Radiotherapy for Cervical Cancer NCT06562166 | Peking Union Medical College Hospital | Phase 2 |
| Active Not Recruiting | Community Clinic Model to Improve Early Detection of Breast and Cervical Cancers in Kenya NCT06572774 | Implenomics | N/A |
| Recruiting | Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer NCT06289751 | Tongji Hospital | Phase 2 |
| Not Yet Recruiting | Cervical Cytology DNA Methylation for Cervical Cancer Screening NCT06557954 | Lei Li | — |
| Not Yet Recruiting | Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A NCT06536855 | Rwanda Biomedical Centre | Phase 4 |
| Recruiting | Reducing Urban Cervical Cancer Disparities NCT06416150 | Fox Chase Cancer Center | N/A |
| Active Not Recruiting | Game Changers for Cervical Cancer Prevention NCT06010160 | RAND | N/A |
| Not Yet Recruiting | The Effect of Motivational Interviewing Based on the COM-B Model NCT06509529 | Ordu University | N/A |
| Completed | What is the Optimal Training Model for Cervical Awareness? NCT06562595 | Izmir City Hospital | N/A |
| Recruiting | Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers NCT06538337 | Jonsson Comprehensive Cancer Center | N/A |
| Recruiting | A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Sec NCT06459180 | Merck Sharp & Dohme LLC | Phase 3 |
| Recruiting | Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management NCT05427058 | University of Brawijaya | N/A |
| Recruiting | INSPIRE: a Multi-Cancer Early Detection Study NCT06440018 | Singlera Genomics Inc. | — |
| Recruiting | German-funded Laparoscopic Approach to Cervical Cancer NCT06489795 | Hannover Medical School | N/A |
| Unknown | Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening NCT06069648 | Chinese University of Hong Kong | N/A |
| Terminated | A Study of PHN-010 in Patients With Advanced Solid Tumors NCT06457997 | Pheon Therapeutics | Phase 1 |
| Recruiting | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069 | Eli Lilly and Company | Phase 1 |
| Active Not Recruiting | Clinical Trial Protocol to Evaluate the Efficacy and Safety of Laparoscopic Surgical Systems for Gynaecologica NCT06598085 | Cornerstone Robotics | N/A |
| Not Yet Recruiting | Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of NCT06456112 | Anhui Provincial Hospital | — |
| Recruiting | NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. NCT06741150 | Newish Technology (Beijing) Co., Ltd. | N/A |
| Recruiting | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194 | ModeX Therapeutics, An OPKO Health Company | Phase 1 / Phase 2 |
| Recruiting | NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer NCT07092007 | Newish Technology (Beijing) Co., Ltd. | N/A |
| Active Not Recruiting | Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachythera NCT06263283 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Not Yet Recruiting | Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: NCT06426056 | Peking University Third Hospital | Phase 2 |
| Completed | Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients NCT06007586 | Sichuan Cancer Hospital and Research Institute | Phase 3 |
| Completed | Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer NCT06705309 | Istanbul University - Cerrahpasa | N/A |
| Active Not Recruiting | Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living with H NCT06402383 | Queen's University | N/A |
| Recruiting | Spectral CT in Radiotherapy for Cervical Cancer NCT06433817 | Peking Union Medical College Hospital | — |
| Recruiting | Proton Therapy for Locally Advanced Cervical Cancer NCT06462378 | University of Aarhus | Phase 2 |
| Not Yet Recruiting | Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors NCT04889742 | Charite University, Berlin, Germany | Phase 2 |
| Recruiting | Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer NCT06289062 | Tongji Hospital | Phase 2 |
| Active Not Recruiting | A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) NCT05973487 | TScan Therapeutics, Inc. | Phase 1 |
| Recruiting | Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Followi NCT04743674 | UNC Lineberger Comprehensive Cancer Center | — |
| Active Not Recruiting | Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer NCT06419673 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) NCT06004011 | Implenomics | N/A |
| Recruiting | Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC NCT06288373 | Tongji Hospital | Phase 2 / Phase 3 |
| Withdrawn | Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Ca NCT06099418 | Nykode Therapeutics ASA | Phase 2 |
| Recruiting | Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer NCT06353061 | Peking Union Medical College Hospital | Phase 2 |
| Recruiting | Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen NCT06251947 | Shandong University | Phase 2 |
| Not Yet Recruiting | CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers NCT06358053 | Corregene Biotechnology Co., Ltd | Phase 1 |
| Recruiting | ASk Questions in GYnecologic Oncology (ASQ-GYO) NCT06339827 | Ira Winer | N/A |
| Active Not Recruiting | A Cervical Cancer Prevention Program in Kenya NCT06411938 | Indiana University | N/A |
| Recruiting | The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies NCT06552598 | Tongji Hospital | Phase 1 |
| Not Yet Recruiting | Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences NCT05789628 | Power Life Sciences Inc. | — |
| Not Yet Recruiting | A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcino NCT06333821 | Biotech Pharmaceutical Co., Ltd. | Phase 3 |
| Not Yet Recruiting | A Novel Smart Speculum Versus a Standard Speculum for Easy Visualisation of the Cervix and Performing Remote C NCT06359431 | GICMED | N/A |
| Unknown | Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project NCT06351228 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Unknown | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis NCT06363123 | Beijing Friendship Hospital | — |
| Recruiting | Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer NCT05764044 | Hospital do Coracao | Phase 3 |
| Recruiting | Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy NCT06024109 | Aesculap AG | — |
| Active Not Recruiting | Dostarlimab and Cobolimab in Advanced Cervical Cancer NCT06238635 | Meghan Shea | Phase 2 |
| Recruiting | Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) NCT06266338 | University of Texas Southwestern Medical Center | Phase 2 |
| Recruiting | A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470 | MacroGenics | Phase 1 |
| Active Not Recruiting | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors NCT06238479 | Eli Lilly and Company | Phase 1 |
| Not Yet Recruiting | Myeloprotection With Trilaciclib in Pan-cancer Population NCT06297811 | Sun Yat-sen University | Phase 2 |
| Recruiting | HPV DNA Self-sampling in a General Practitioner's Office. NCT06253169 | Patient Organization Veronica | — |
| Recruiting | Role of MRI Assessment in Fertility Sparing Treatment for Cervical Cancer at Staging and Follow-up and for Ide NCT06877065 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging NCT06260358 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Unknown | Development and Evaluation of an Artificial Intelligence Tool for Colposcopy Assistance NCT06208319 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06172478 | Daiichi Sankyo | Phase 2 |
| Recruiting | A Study of Concurrent Chemoradiotherapy Followed by Cadonilimab（AK104） for Newly Diagnosed Local Advanced Cerv NCT06251388 | West China Second University Hospital | Phase 2 |
| Recruiting | GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Sol NCT06265025 | GeneMedicine Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolesc NCT06243666 | Xiamen University | — |
| Recruiting | mSaada: A Mobile Health Tool NCT05848557 | Duke University | N/A |
| Recruiting | Pocket Colposcopy Using CARE Algorithm NCT06458062 | Duke University | N/A |
| Recruiting | Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors NCT06293898 | SystImmune Inc. | Phase 1 |
| Active Not Recruiting | Evaluation of the Cancer Tracking System (CATSystem) NCT06286462 | University of Kansas Medical Center | N/A |
| Recruiting | Toripalimab Combined With Definitive CCRT for LACC Patients NCT06256224 | Ruijin Hospital | N/A |
| Recruiting | Development of an Imaging Prediction Model for Pelvic Lymph Node Metastasis of Cervical Cancer Using Artificia NCT06448897 | Obstetrics & Gynecology Hospital of Fudan University | — |
| Recruiting | Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors NCT06276309 | Fujian Maternity and Child Health Hospital | — |
| Unknown | HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China NCT06238284 | Chongqing University Cancer Hospital | — |
| Recruiting | Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer NCT06511726 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Recruiting | A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing NCT06155396 | RemeGen Co., Ltd. | Phase 2 |
| Recruiting | MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial NCT05975593 | Washington University School of Medicine | N/A |
| Completed | Coughing at Time of Cervical Biopsy NCT06149598 | Zydolab - Institute of Cytology and Immune Cytochemistry | N/A |
| Active Not Recruiting | Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France NCT05924217 | Centre Hospitalier Universitaire de Nīmes | — |
| Not Yet Recruiting | Study on AUNIP as a Novel Tumor Marker for Cervical Cancer NCT06118463 | Lin Yuan | — |
| Not Yet Recruiting | MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy NCT06197126 | Fujian Cancer Hospital | — |
| Not Yet Recruiting | Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer NCT06149767 | Fujian Cancer Hospital | Phase 2 |
| Unknown | ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study NCT06095674 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 1 |
| Active Not Recruiting | Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women NCT06197802 | Xiamen University | — |
| Recruiting | Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants NCT06291311 | University Hospital Tuebingen | — |
| Recruiting | BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer NCT06123884 | Bio-Thera Solutions | Phase 2 / Phase 3 |
| Recruiting | Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selectio NCT06042543 | International Agency for Research on Cancer | N/A |
| Not Yet Recruiting | Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer. NCT06128460 | Obstetrics & Gynecology Hospital of Fudan University | Phase 2 |
| Not Yet Recruiting | A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy NCT06101966 | Fujian Cancer Hospital | — |
| Unknown | Point-of-Care Ultraviolet Microscopy for Cervical Cancer Screening NCT05899647 | University of Arizona | N/A |
| Recruiting | MR-guidance in Chemoradiotherapy for Cervical Cancer NCT06142760 | Juergen Debus | N/A |
| Recruiting | ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services NCT06128304 | University of California, San Diego | N/A |
| Completed | Feasibility of Optimizing Organized Cervical Cancer Screening by Urine Self-sampling NCT06259448 | University Hospital, Bordeaux | N/A |
| Recruiting | Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors NCT05799274 | Radiopharm Theranostics, Ltd | Phase 1 |
| Recruiting | A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and NCT05990803 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | PROton Therapy for Post Surgical Treatment of GYNecologic Cancer NCT05758688 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Recruiting | Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Meta NCT06047379 | Neonc Technologies, Inc. | Phase 1 / Phase 2 |
| Recruiting | Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer NCT06093438 | Tianjin Medical University Cancer Institute and Hospital | Phase 1 / Phase 2 |
| Not Yet Recruiting | Hyperpolarized 13C MRI for Cancer Immunotherapy NCT05805358 | Chang Gung Memorial Hospital | Phase 2 |
| Unknown | Randomized Controlled, Open Clinical Study on Efficacy and Safety of Acupuncture for Bladder Function Recovery NCT06095882 | Qilu Hospital of Shandong University | N/A |
| Recruiting | HRYZ-T101 Injection for HPV18 Positive Solid Tumor NCT05952947 | HRYZ Biotech Co. | Phase 1 |
| Terminated | Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Can NCT06034860 | Molecular Templates, Inc. | Phase 1 |
| Recruiting | Improving Muslim Women's Uptake of Cancer Screening (IMCAN) NCT06106165 | University of Sunderland | N/A |
| Active Not Recruiting | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers NCT05891171 | Arcus Biosciences, Inc. | Phase 1 |
| Recruiting | Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC) NCT06083103 | Centre Paul Strauss | — |
| Not Yet Recruiting | AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer NCT06062589 | Peking University Third Hospital | — |
| Recruiting | Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignanc NCT05979610 | University of Utah | Phase 2 |
| Unknown | Fat Grafting for Vaginal Stenosis in Gynaelogical Cancer NCT06015360 | Royal Marsden NHS Foundation Trust | N/A |
| Not Yet Recruiting | Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer NCT06039891 | Peking Union Medical College Hospital | Phase 2 |
| Active Not Recruiting | Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement NCT06577220 | Baylor College of Medicine | N/A |
| Active Not Recruiting | A Study of ADRX-0706 in Select Advanced Solid Tumors NCT06036121 | Adcentrx Therapeutics | Phase 1 |
| Completed | Promise Women Project NCT05862844 | Mark Dignan, PhD | N/A |
| Completed | Elimisha HPV (Human Papillomavirus) NCT05736588 | Duke University | N/A |
| Recruiting | Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors W NCT06022757 | Evopoint Biosciences Inc. | Phase 1 / Phase 2 |
| Recruiting | A Cohort Study of Uterine Malignancies NCT05635123 | Women's Hospital School Of Medicine Zhejiang University | — |
| Recruiting | Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) NCT05743517 | Northwestern University | N/A |
| Recruiting | Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies NCT05914974 | University Hospital Tuebingen | — |
| Active Not Recruiting | Efficacy of Offering a Self-sampling Device by the GP to Reach Underscreened Women NCT05656976 | University Ghent | N/A |
| Recruiting | Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preservin NCT06209294 | Xiaohua Wu | Phase 2 |
| Recruiting | Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana NCT05952141 | Abramson Cancer Center at Penn Medicine | N/A |
| Recruiting | Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE) NCT06691776 | The Netherlands Cancer Institute | N/A |
| Recruiting | The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Ad NCT05749887 | Chongqing University Cancer Hospital | N/A |
| Recruiting | Improving Diagnostics in Cervical Dysplasia NCT05283421 | University of Aarhus | N/A |
| Recruiting | Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Sol NCT05983432 | SystImmune Inc. | Phase 1 |
| Recruiting | VIBE - Virtual Image Guided Brachytherapy Emulation for Locally Advanced Cervical Cancer (LACC) NCT06394297 | Fundacao Champalimaud | N/A |
| Recruiting | SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas NCT06544720 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Recruiting | Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer NCT05554276 | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | Phase 2 |
| Recruiting | Adaptation and Implementation of a Patient Navigation Program for Cervical Cancer Screening Across Contexts in NCT05544084 | University of Illinois at Chicago | N/A |
| Unknown | Identification of a MOLecuLar Signature in Locally Advanced Cervical Cancer Patients NCT06016868 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Withdrawn | A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of NCT05998941 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 |
| Enrolling By Invitation | A Review of Cervical Cancer Screening Practices in Women Age >65 NCT06431724 | Sarasota Memorial Health Care System | — |
| Completed | A Chatbot Intervention for Reducing HPV Vaccine Hesitancy NCT05959564 | University of Maryland, College Park | N/A |
| Recruiting | A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies NCT05955105 | Innolake Biopharm | Phase 1 / Phase 2 |
| Recruiting | Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical NCT05173272 | Sichuan Cancer Hospital and Research Institute | Phase 3 |
| Unknown | Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine NCT06261892 | WomenX Biotech Limited | N/A |
| Unknown | Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstr NCT06261879 | WomenX Biotech Limited | N/A |
| Recruiting | a Single-arm, Single-center, Open Clinical Study NCT06431100 | Beijing Geekgene Technology Co., LTD | — |
| Active Not Recruiting | Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors NCT05858736 | OncoC4, Inc. | Phase 1 |
| Active Not Recruiting | A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Sol NCT05812027 | TScan Therapeutics, Inc. | — |
| Recruiting | Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions NCT06284031 | National University Hospital, Singapore | N/A |
| Terminated | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors NCT05563272 | Telix Pharmaceuticals (Innovations) Pty Ltd | Phase 2 |
| Recruiting | A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer NCT05838521 | Yale University | Phase 2 |
| Not Yet Recruiting | Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immun NCT05824494 | Women's Hospital School Of Medicine Zhejiang University | Phase 2 |
| Active Not Recruiting | Screening for Early Cervical Cancer Detection NCT06550583 | Assiut University | — |
| Unknown | Sirius in Gynaecological Laparoscopic Surgery NCT05048407 | Precision Robotics (Hong Kong) Limited | N/A |
| Recruiting | Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study NCT05857631 | Tata Memorial Centre | N/A |
| Completed | Self-collected Vaginal and Urine Samples in HIV-positive Women NCT05783167 | University of Aarhus | — |
| Recruiting | A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Seque NCT06028724 | Centro di Riferimento Oncologico - Aviano | — |
| Not Yet Recruiting | Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Canc NCT05879796 | Peking University Third Hospital | — |
| Recruiting | Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa NCT05413798 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Active Not Recruiting | Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Can NCT05824468 | Sun Yat-sen University | Phase 2 |
| Completed | Transcutaneous Electrical Nerve Stimulation in Nerve-Sparing Radical Hysterectomy: Effects on Bladder Manageme NCT07070687 | Fudan University | N/A |
| Recruiting | A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Sol NCT06508307 | GONGCHU Biotechnology Co., Ltd | Phase 1 |
| Completed | Dry Run of the ScreenUrSelf Trial NCT05996796 | Universiteit Antwerpen | N/A |
| Recruiting | MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA) NCT05937958 | UMC Utrecht | — |
| Completed | Home-based Cervical Cancer Screening Project NCT06166420 | Prof. Patrick Petignat | N/A |
| Active Not Recruiting | Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women NCT06776055 | Shanghai Zerun Biotechnology Co.,Ltd | — |
| Completed | Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living NCT05413811 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Unknown | HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor NCT05787535 | HRYZ Biotech Co. | Phase 1 |
| Unknown | Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer NCT05883670 | Shandong University | — |
| Recruiting | E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226 | Christian Hinrichs | Phase 2 |
| Completed | Results Comparison of Cervical Cancer Early Detection Using Cerviray With VIA Test NCT06518070 | Universitas Padjadjaran | — |
| Completed | iMproving thE DIagnostics And Treatment Of ceRvical Precancer NCT05870787 | University of Aarhus | — |
| Completed | HPV Self-Sampling in Somali Women (Isbaar Project) NCT05453006 | University of Minnesota | N/A |
| Recruiting | Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer NCT05817214 | Zhongnan Hospital | Phase 2 |
| Completed | AK104 in Neoadjuvant Treatment of Cervical Cancer NCT05227651 | Akeso | Phase 2 |
| Recruiting | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib NCT05512208 | University of Oklahoma | Phase 2 |
| Unknown | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and End NCT05812677 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Completed | Clinical Correlation Between Self-collected and Physician-collected HPV Screening Kits NCT05679141 | Switch Health Solutions Inc. | — |
| Recruiting | Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer NCT06455072 | Fujian Cancer Hospital | Phase 2 |
| Withdrawn | Community Outreach-based Study to Increase Cervical Cancer Screening Among Hispanic Women in Cleveland NCT05470309 | MetroHealth Medical Center | — |
| Recruiting | Radiomics-based Malnutrition for Cervical Cancer. NCT05709769 | Zhejiang Provincial People's Hospital | — |
| Recruiting | Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) NCT05872724 | Suzhou Municipal Hospital | Phase 2 |
| Active Not Recruiting | Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With NCT05438420 | Qurient Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | First in Human Study of IMGN151 in Recurrent Gynaecological Cancers NCT05527184 | AbbVie | Phase 1 |
| Unknown | A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparosc NCT05318625 | Precision Robotics (Hong Kong) Limited | N/A |
| Unknown | Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma NCT05259540 | Women's Hospital School Of Medicine Zhejiang University | Phase 2 |
| Unknown | Clinical Value of the Fertility-preserving Surgery in Cervical Cancer NCT05806125 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Completed | Cervical Cancer Prevention for Black Adults NCT04927494 | Adebola Adegboyega | N/A |
| Recruiting | Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tu NCT05283330 | Orano Med LLC | Phase 1 |
| Recruiting | Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION) NCT05475171 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Ch NCT05584332 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |